BT-101 (Benethera)

N/A

Report date: 2026/01/20 09:30:05
NME

Base Information

Drug NameBT-101 (Benethera)
Drug Alias NameBT-101
ClassificationSmall molecules
Mechanisms of ActionG-protein coupled receptor modulatorsRegulatory T-lymphocytes modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBenethera (Shaoxing) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBenethera (Shaoxing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A